Therapeutic Utility and Adverse Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs in Inflammatory Arthritis

Therapeutic Utility and Adverse Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs in Inflammatory Arthritis

Targeting specific pathologic pro-inflammatory cytokines or related molecules leads to excellent therapeutic effects in inflammatory arthritis, including rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. Most of these agents, known as biologic disease-modifying anti-rheumatic dr...

Full description

Bibliographic Details
Main Authors: Hong Ki Min, Se Hee Kim, Hae-Rim Kim, Sang-Heon Lee
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:International Journal of Molecular Sciences
Subjects:
monoclonal antibody
biologic disease-modifying anti-rheumatic drug
rheumatoid arthritis
spondyloarthritis
psoriatic arthritis
inflammatory arthritis
Online Access:https://www.mdpi.com/1422-0067/23/22/13913

Internet

https://www.mdpi.com/1422-0067/23/22/13913

Similar Items